Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NOrepinephrine and VasoprEssin Versus Norepinephrine aLone in Critically Ill Patients With Septic Shock (NOVEL Trial)

NCT02454348 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.

NCT NCT02454348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02454348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NOrepinephrine and VasoprEssin Versus Norepinephrine aLone in Critically Ill Patients With Septic Shock (NOVEL Trial)
Lead sponsor
University of Arkansas
Phase
Phase 4
Overall status
Withdrawn
Start date
November 1, 2015
Completion date
November 27, 2017
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

shock, septic